Novel dual PPARα/γ agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects
Guru Bhavimani, Akhilesh K. Tamrakar, Santhepete Nanjundaiah Manjula, B. R. Prashantha Kumar
Topics & Concepts
GLUT4Insulin resistanceEndocrinologyInternal medicineRosiglitazonePioglitazoneSteatosisPeroxisome proliferator-activated receptorFatty liverAMPKHyperinsulinemiaGlucose uptakeAdipocyteInsulinBiologyMedicineType 2 diabetesDiabetes mellitusAdipose tissueReceptorProtein kinase AKinaseBiochemistryDiseaseMetabolism, Diabetes, and CancerPeroxisome Proliferator-Activated ReceptorsPancreatic function and diabetes